Bradley Louis Radoff, Director at ENZO BIOCHEM INC (ENZ), bought 120,000 shares at $2.20 ($264K) on 2022-07-05, disclosed to the SEC on 2022-07-06.
Open-market purchase of $264k ENZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| KVHI | SELL | 2026-05-29 | $392K | — | Filing → |
| KVHI | BUY | 2026-02-12 | $188K | — | Filing → |
| HHS | BUY | 2024-12-06 | $100K | — | Filing → |